WJ-47156

N/A

Report date: 2025/05/27 14:25:56
NME

Base Information

Drug NameWJ-47156
Drug Alias NameWJ47156WJ-47156JS125JS-125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 1 inhibitorsHistone deacetylase 2 inhibitorsHistone deacetylase 3 inhibitors
TargetsHistone deacetylase 1Histone deacetylase 2Histone deacetylase 3
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Junshi Biosciences Co LtdWigen Biomedicine technology (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Junshi Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A